Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
US7582644B2 · kind B2 · utility
4Cited by
0References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 2003 |
| Grant date | Sep 1, 2009 |
| Priority date | — |
| Expiry date | Feb 8, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula (I), pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof for the treatment of asthma, allergic rhinitis, COPD, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis or cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.